1,700
Views
4
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma

, MD, , PhD, MPH, , PhD, , MD, PhD & , MD
Pages 187-193 | Received 08 Apr 2015, Accepted 03 Jul 2015, Published online: 15 Sep 2015

References

  • Robinson CA, Tsourounis C. Inhaled corticosteroid metered-dose inhalers: how do variations in technique for solutions versus suspensions affect drug distribution? Ann Pharmacother 2013;47:416–420
  • Leach C. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol 1999;104:S250–S252
  • Baddar S, Jayakrishnan B, Al-Rawas OA. Asthma control: importance of compliance and inhaler technique assessments. J Asthma 2014;51:429–434
  • Levy ML, Hardwell A, McKnight E, Holmes J. Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis. Prim Care Respir J 2013;22:406–411
  • Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, US Department of Health and Human Services; 2007. Available from: http://www.nhlbi.nih.gov/health-pro/guidelines/current/asthma-guidelines/full-report [last accessed 18 August 2015]
  • Ramsdell JW, Klinger NM, Ekholm BP, Colice GL. Safety of long-term treatment with HFA albuterol. Chest 1999;115:945–951
  • Tinkelman DG, Bleecker ER, Ramsdell J, Ekholm BP, Klinger NM, Colice GL, Slade HB. Proventil HFA and ventolin have similar safety profiles during regular use. Chest 1998;113:290–296
  • Bondesson E, Friberg K, Soliman S, Lofdahl CG. Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma. Respir Med 1998;92:325–330
  • Golish J, Curtis-McCarthy P, McCarthy K, Kavuru M, Wagner W, Beck G, Eng P. Albuterol delivered by metered-dose inhaler (MDI), MDI with spacer, and Rotahaler device – a comparison of efficacy and safety. J Asthma 1998;35:373–379
  • Geoffroy P, Lalonde RL, Ahrens R, Clarke W, Hill MR, Vaughan LM, Grossman J. Clinical comparability of albuterol delivered by the breath-actuated inhaler (Spiros) and albuterol by MDI in patients with asthma. Ann Allergy Asthma Immunol 1999;82:377–382
  • Price D, Chrystyn H, Kaplan A, Haughney J, Roman-Rodriguez M, Burden A, Chisholm A, et al. Effectiveness of same versus mixed asthma inhaler devices: a retrospective observational study in primary care. Allergy Asthma Immunol Res 2012;4:184–191
  • Ostrom NK, Taveras H, Iverson H, Pearlman DS. A novel albuterol multidose dry powder inhaler in adult and adolescent patients with exercise-induced bronchoconstriction: a single-dose study [abstract]. Presented at: Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology; 2014 Nov 6–10; Atlanta, GA
  • Raphael G, Taveras H, Iverson H, O'Brien C, Miller D. Efficacy of albuterol multidose dry powder inhaler versus placebo in subjects 12 years of age and older with persistent asthma [poster P74]. Presented at: Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology; 2014 Nov 6–10; Atlanta, GA
  • Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179–187
  • Gross G, Cohen RM, Guy H. Efficacy response of inhaled HFA-albuterol delivered via the breath-actuated Autohaler inhalation device is comparable to dose in patients with asthma. J Asthma 2003;40:487–495
  • Ventolin HFA [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2012
  • Proair HFA [package insert]. Horsham, PA: Teva Respiratory, LLC; 2012
  • Lumry W, Noveck R, Weinstein S, Barnhart F, Vandermeer A, Murray A, Reisner C. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma. Ann Allergy Asthma Immunol 2001;86:297–303
  • Hamilos DL, D'Urzo A, Levy RJ, Marcus M, Tripp K, Parsey M, Baumgartner RA, et al. Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. Ann Allergy Asthma Immunol 2007;99:540–548
  • Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005;50:1360–1374
  • Al-Jahdali H, Ahmed A, Al-Harbi A, Khan M, Baharoon S, Bin SS, Halwani R, et al. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol 2013;9:8
  • Dalcin PT, Grutcki DM, Laporte PP, Lima PB, Menegotto SM, Pereira RP. Factors related to the incorrect use of inhalers by asthma patients. J Bras Pneumol 2014;40:13–20
  • Giraud V, Allaert FA, Roche N. Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med 2011;105:1815–1822
  • Onyedum C, Desalu O, Nwosu N, Chukwuka C, Ukwaja K, Ezeudo C. Evaluation of inhaler techniques among asthma patients seen in Nigeria: an observational cross sectional study. Ann Med Health Sci Res 2014;4:67–73
  • Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011;105:930–938
  • Reznik M, Silver EJ, Cao Y. Evaluation of MDI-spacer utilization and technique in caregivers of urban minority children with persistent asthma. J Asthma 2014;51:149–154
  • Ottenbros S, Teichert M, de Groot R, Griens F, Sodihardjo F, Wensing M, de Gier JJ. Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients. Int J Clin Pharm 2014;36:336–344